-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn
Christian Burri
Commentary: Clinical Investigation
-
Chemotherapy of advanced non-small-cell lung cancer: current landscape
Athanasios G Pallis, Rafal Dziadziuszko & Mary OBrien
Review: Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapy of advanced non-small-cell lung cancer: current landscape
Athanasios G Pallis, Rafal Dziadziuszko & Mary OBrien
Review: Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapy of advanced non-small-cell lung cancer: current landscape
Athanasios G Pallis, Rafal Dziadziuszko & Mary OBrien
Review: Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapy of advanced non-small-cell lung cancer: current landscape
Athanasios G Pallis, Rafal Dziadziuszko & Mary OBrien
Review: Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapy of advanced non-small-cell lung cancer: current landscape
Athanasios G Pallis, Rafal Dziadziuszko & Mary OBrien
Review: Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapy of advanced non-small-cell lung cancer: current landscape
Athanasios G Pallis, Rafal Dziadziuszko & Mary OBrien
Review: Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapy of advanced non-small-cell lung cancer: current landscape
Athanasios G Pallis, Rafal Dziadziuszko & Mary OBrien
Review: Clinical Trail Outcomes: Clinical Investigation
-
Chemotherapy of advanced non-small-cell lung cancer: current landscape
Athanasios G Pallis, Rafal Dziadziuszko & Mary OBrien
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design and conduct of clinical drug trials in older cancer patients
Athanasios G Pallis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design and conduct of clinical drug trials in older cancer patients
Athanasios G Pallis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design and conduct of clinical drug trials in older cancer patients
Athanasios G Pallis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design and conduct of clinical drug trials in older cancer patients
Athanasios G Pallis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design and conduct of clinical drug trials in older cancer patients
Athanasios G Pallis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design and conduct of clinical drug trials in older cancer patients
Athanasios G Pallis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design and conduct of clinical drug trials in older cancer patients
Athanasios G Pallis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design and conduct of clinical drug trials in older cancer patients
Athanasios G Pallis
Review: Clinical Trail Outcomes: Clinical Investigation
-
Research involving pregnant women: trials and tribulations
Francoise Baylis, Scott A. Halperin
Clinical Trail Perspective: Clinical Investigation
-
Research involving pregnant women: trials and tribulations
Francoise Baylis, Scott A. Halperin
Clinical Trail Perspective: Clinical Investigation
-
Research involving pregnant women: trials and tribulations
Francoise Baylis, Scott A. Halperin
Clinical Trail Perspective: Clinical Investigation
-
Research involving pregnant women: trials and tribulations
Francoise Baylis, Scott A. Halperin
Clinical Trail Perspective: Clinical Investigation
-
Research involving pregnant women: trials and tribulations
Francoise Baylis, Scott A. Halperin
Clinical Trail Perspective: Clinical Investigation
-
Research involving pregnant women: trials and tribulations
Francoise Baylis, Scott A. Halperin
Clinical Trail Perspective: Clinical Investigation
-
Research involving pregnant women: trials and tribulations
Francoise Baylis, Scott A. Halperin
Clinical Trail Perspective: Clinical Investigation
-
Research involving pregnant women: trials and tribulations
Francoise Baylis, Scott A. Halperin
Clinical Trail Perspective: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
First drug in over 50 years gains EU approval for stroke prevention in atrial fibrillation
News and Views: Clinical Investigation
-
Tweaking potential research participants to meet clinical trial eligibility criteria: ethical concerns and scientific implications
Blair Henry, Yulia Lin, Jeannie Callum
Editorial: Clinical Investigation
-
Tweaking potential research participants to meet clinical trial eligibility criteria: ethical concerns and scientific implications
Blair Henry, Yulia Lin, Jeannie Callum
Editorial: Clinical Investigation
-
Tweaking potential research participants to meet clinical trial eligibility criteria: ethical concerns and scientific implications
Blair Henry, Yulia Lin, Jeannie Callum
Editorial: Clinical Investigation
-
Tweaking potential research participants to meet clinical trial eligibility criteria: ethical concerns and scientific implications
Blair Henry, Yulia Lin, Jeannie Callum
Editorial: Clinical Investigation
-
Tweaking potential research participants to meet clinical trial eligibility criteria: ethical concerns and scientific implications
Blair Henry, Yulia Lin, Jeannie Callum
Editorial: Clinical Investigation
-
Tweaking potential research participants to meet clinical trial eligibility criteria: ethical concerns and scientific implications
Blair Henry, Yulia Lin, Jeannie Callum
Editorial: Clinical Investigation
-
Tweaking potential research participants to meet clinical trial eligibility criteria: ethical concerns and scientific implications
Blair Henry, Yulia Lin, Jeannie Callum
Editorial: Clinical Investigation
-
Tweaking potential research participants to meet clinical trial eligibility criteria: ethical concerns and scientific implications
Blair Henry, Yulia Lin, Jeannie Callum
Editorial: Clinical Investigation